EP0209576A1 - System und verfahren zur behandlung von membranen - Google Patents
System und verfahren zur behandlung von membranenInfo
- Publication number
- EP0209576A1 EP0209576A1 EP19860900972 EP86900972A EP0209576A1 EP 0209576 A1 EP0209576 A1 EP 0209576A1 EP 19860900972 EP19860900972 EP 19860900972 EP 86900972 A EP86900972 A EP 86900972A EP 0209576 A1 EP0209576 A1 EP 0209576A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- membrane
- fluid
- container
- jacket
- define
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 256
- 238000000034 method Methods 0.000 title claims description 61
- 238000012545 processing Methods 0.000 title abstract description 37
- 239000012530 fluid Substances 0.000 claims abstract description 157
- 230000009975 flexible effect Effects 0.000 claims abstract description 55
- 239000012634 fragment Substances 0.000 claims abstract description 48
- 239000004744 fabric Substances 0.000 claims abstract description 11
- 239000000463 material Substances 0.000 claims description 51
- 230000037361 pathway Effects 0.000 claims description 28
- -1 polyethylene Polymers 0.000 claims description 13
- 239000004698 Polyethylene Substances 0.000 claims description 12
- 229920000573 polyethylene Polymers 0.000 claims description 12
- 238000012546 transfer Methods 0.000 claims description 12
- 238000004891 communication Methods 0.000 claims description 11
- 239000011159 matrix material Substances 0.000 claims description 10
- 238000007789 sealing Methods 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 4
- 230000002093 peripheral effect Effects 0.000 claims 6
- 150000001768 cations Chemical class 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 9
- 238000011835 investigation Methods 0.000 abstract description 6
- 239000007787 solid Substances 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 3
- 210000004379 membrane Anatomy 0.000 description 167
- 108020004414 DNA Proteins 0.000 description 25
- 239000000523 sample Substances 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- 230000008569 process Effects 0.000 description 12
- 125000006850 spacer group Chemical group 0.000 description 8
- 239000000020 Nitrocellulose Substances 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- 238000000137 annealing Methods 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229920002457 flexible plastic Polymers 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- WRRQKFXVKRQPDB-UHFFFAOYSA-N 2-(2-aminophenyl)sulfanylaniline Chemical compound NC1=CC=CC=C1SC1=CC=CC=C1N WRRQKFXVKRQPDB-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229920000936 Agarose Polymers 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000005315 distribution function Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940086255 perform Drugs 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D57/00—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C
- B01D57/02—Separation, other than separation of solids, not fully covered by a single other group or subclass, e.g. B03C by electrophoresis
Definitions
- the present invention relates generally to those apparatus and methods of analysis and investiga- tion which utilize a solid support in the form of mem ⁇ branes or similar media upon which selected specimens are transferred to or otherwise placed for analysis and evaluation. More particularly, the present invention relates to and is suited for use in those areas of biotechnology and molecular biology that utilize mem ⁇ branes upon which selected specimens are deposited for analysis, investigation, hybridization, and the like, such specimens including molecules and molecule frag ⁇ ments of DNA, RNA, and proteins. Many laboratory and analytical procedures involve the use of a sheet-like membrane, such as nitrocellulose, treated nitrocellulose, and similar materials, upon which one or more specimens are deposited with the membrane then subjected to further processing steps to analyze, identify, or isolate selected of the specimens.
- a sheet-like membrane such as nitrocellulose, treated nitrocellulose, and similar materials
- fragments are then transferred to a nitrocellulose membrane for subsequent processing to produce a visible indication, for example, by autoradiograph, of the position on the membrane of the target fragments.
- fragments of DNA molecules of unlike size are separated, for example, by ultra- centrifuging or column chromatography, into separate samples of like size.
- the separate samples are then deposited onto a nitrocellulose membrane with each sample occupying a dot-like area on the membrane.
- the membrane is then subjected to additional processing steps to again yield an autoradiograph which indicates the position of the target fragments on the membrane.
- the present invention can be best understood in the context of the Southern blot procedure, selected steps of which are illustrated in Figs. 1, 2, and 3.
- source DNA molecules are cleaved into fragments of differing length by restric ⁇ tion enzymes that recognize selected sites on the DNA molecule and cleave the molecule at those recognition sites into molecule fragments of varying lengths.
- the molecular fragments are separated as a function of their length.
- the molecular fragments are electrophoretically separated. As schematically illus- trated in Fig.
- an agarose or polyacrylamide gel slab G is prepared with electrodes, schematically illustrated at El and E2, aligned along opposite edges of the slab.
- the source mixture of molecule fragments is deposited on the slab G and the electrodes are connected to a suitable source of electrical energy to apply a directed electric field across the gel slab between the two electrodes. Since the molecule fragments have a net charge, they will migrate through and across the slab G toward the oppositely charged electrode with the speed of transportation being a function, in part, of the molecular weight of the fragment.
- mole ⁇ cules of similar size will be grouped with one another in spaced apart, band-like groupings with the largest fragments grouped relatively close to the initial position and the smallest fragments grouped furthest from the initial position to thus effectively separate the molecules as a function of size.
- the fragments are transferred from the gel to a membrane M having an affinity for the particular mole ⁇ cule fragments.
- a membrane M having an affinity for DNA fragments have been separated in the gel slab G
- a sheet-like membrane M of nitro ⁇ cellulose is laid upon one surface of the gel.
- another membrane having an affinity to RNA such as diazon- benzyloxymethyl cellulose (DBM) paper or aminophen- ylthioether (APT) paper activated to the diazo-form (DPT) may be used.
- DBM diazon- benzyloxymethyl cellulose
- APT aminophen- ylthioether
- the molecules in the gel matrix can be transferred to the membrane M by the Southern transfer method by establishing a capillary transfer through the gel and the contiguous membrane M.
- the gel slab G and the membrane M are placed upon the upper surface of an absorbant material S, which may take the form of a stack of blotting papers, saturated with a blotting buffer solution.
- a dry absorbant material D which may also take the form of a stack of absorbant blotting sheets, is placed on the upper side of the membrane M so that a capillary transfer is established from the saturated material S through the gel slab G and the membrane M to the dry or unsaturated absorbant mate ⁇ rial.
- the electrophoretically separated DNA molecules are eluted from the gel matrix and transferred to the membrane M with the molecular fragments binding to the membrane.
- This transfer process can be assisted electrophoretically by establishing an electric field across the absorber stack to assist in moving the molecules from the gel matrix to the membrane M. Regardless of the particular gel-to-membrane transfer mechanism employed, the resulting membrane M will have groupings of DNA molecule fragments bound thereto.
- the membrane M is then subjected to a number of fluid treatment steps to identify a particular group ⁇ ing of target DNA fragments on the membrane.
- the transferred DNA fragments are thermally "fixed" to the membrane M by heating at a selected temperature for a period of time sufficient to effect fixing.
- a solution of DNA or RNA "probe" fragments complementary to the target fragments is prepared with the probe fragments coupled to a radio ⁇ active tracer material.
- the membrane M is then washed in the probe solution, for example, by immersion in a capped bottle or heat sealed plastic bag containing the probe solution, for an incubation period sufficient to allow the radio-tagged probe fragments to hybridize with their complementary target fragments on the mem- brane. Once sufficient time for annealing has lapsed, the membrane M is then washed and treated in a series of buffer solutions, such as ribonuclease, at differing temperatures and concentrations designed to remove the excess unhybridized probe solution. The resulting membrane M is dried and retains only the original DNA fragments and the hybridized probe and target radio- tagged fragments. Thereafter, the membrane M is processed to yield a visible indication of the location of the annealed target/probe molecules.
- buffer solutions such as ribonuclease
- the visible indication is obtained by laying the membrane against one side of a radiation sensitive film so that the film is exposed by beta particle radiation from the radioactive tag.
- the location of the hybridized probe/target molecule fragments on the membrane M is revealed by the developed film.
- the typically thin (e.g., 0.001 to 0.005 inch) and structurally weak membrane is subject to many manual handling steps over a relatively long period of time.
- conventional membrane-dependent procedures require a rather high level of skill to insure valid and reproducible results and to minimize physical damage to or contamination of the membrane.
- the use of membranes is not conducive to time and cost efficiencies that would allow transfer of the membrane- based methodologies to clinical, industrial, agricul ⁇ tural, or other applications where cost and time effectiveness is imperative.
- a membrane processing container is defined by a flexible wall jacket having a sealable open end and fluid ports in communication with the interior of the jacket and through which various fluids can be intro- quizd into and removed from the container.
- a sample membrane is supported on at least one side by a mem ⁇ brane support having surface characteristics that define a multitude of fluid pathways across the surface of the membrane. The supported membrane is placed in the flexible wall jacket which is then sealed, so that the membrane can be exposed to various fluids introduced into and removed from the jacket through the fluid ports.
- the pressure in the flexible wall jacket is reduced to a pressure below local ambient so that the flexible walls collapse against the supported membrane with the membrane support cooperating with the flexible walls of the jacket to define fluid distribution channels along " at least two edges of the supported membrane.
- Treatment fluids are introduced into one of the fluid ports and flow into one of the fluid channels defined along an edge of the supported membrane and flow across the s.urface of the membrane via the multiple pathways to the other fluid channel defined along the other edge of the membrane to the outlet port.
- the membrane treatment container is defined by a flexible plastic jacket that is closed at one end and open at the other.
- the mem ⁇ brane support is defined by a sheet of finely woven or perforated flexible plastic that overlay the opposite surfaces of the membrane with the interstices of the woven material defining multiple fluid pathways across the opposite surfaces of the membrane.
- the edges of the woven support are each provided with an edge spacer that cooperates with the flexible walls to create a fluid channel along opposite edges of the supported membrane with each channel communicating with respective fluid entry and removal ports for introducing or removing fluid from the container.
- the container and the membrane are mounted on a wire frame that includes an elongated clamp for sealing the open end of the container.
- Treatment solutions including probe, buffer, and wash solutions can then be introduced into one of the fluid ports to be distributed in the connected fluid channel along one edge of the supported membrane with the fluid then flowing through the multiple path ⁇ ways across the opposite surfaces of the membrane to the other fluid channel on the opposite edge of the membrane for removal through the other fluid port.
- the best mode of the present invention is in analytical procedures involving the identification of selected molecules bound to a membrane, especially DNA and RNA molecules and molecule fragments, and proteins.
- a nitrocellulose membrane is sandwiched between the open-weave sheets of the membrane support and utilized in the Southern blot procedure whereby DNA molecules are eluted by capillary action from a gel and transferred through the open- weave material of the membrane support to the membrane.
- the mesh supported membrane is then inserted into the open-ended flexible plastic jacket.
- the plastic jacket is mounted in the wire frame which includes a clamp for sealing the open end of the jacket and support points for attachment to the fluid ports.
- Fluid communication is achieved with the interior of the jacket, e.g., by attaching one of the ports to a fluid supply and the other of the ports to a vacuum source using flexible tubing or, where desired, using a hypodermic needle penetrating a septum provided in one or both of the fluid ports.
- the container and frame are then mounted on a stand and the flexible walls of the container are collapsed onto the mesh supported membrane by creating a below ambient pressure differential through one of the ports.
- the strips provided on the opposite edges of the support mesh cooperate with the collapsed flexi- ble walls of the container to define fluid channels on the opposite lateral edges of the support mesh with each channel in fluid communication with respective ports and with each other via the multitude of fluid pathways extending across the opposite surfaces of the membrane.
- Various solutions including radio-tagged or color-yielding probe solutions, buffer solutions, and wash solutions can be introduced into one of the ports to flow along the fluid channel defined on one edge of the mesh-supported membrane and then across both sur- faces of the membrane via the multiple fluid pathways created by the surface characteristics of the mesh to the fluid channel on the opposite lateral edge and then to the outlet port.
- the present invention thus provides apparatus and methods for generally improving procedures involving the handling and treatment of membrane-bound specimens, particularly procedures involving the analysis of membrane-bound DNA, RNA, and proteins, in such a way that the procedures are more time, material, and cost efficient to provide improved procedures better suited for clinical, industrial, and agricultural applications and eventual automation.
- the improved procedures consequent to the present invention provide greater immunity to mishandling and damage of the specimen-bound membrane as well as reduced vulnerability to contamina ⁇ tion.
- Fig. 1 is an isometric view, in schematic form, of a gel slab useful for the electrophoretic separation of DNA molecule fragments
- Fig. 2 is an isometric view of the gel slab of Fig. 1 with a membrane being laid upon one surface of the gel slab;
- Fig. 3 is a side elevation view of the gel and membrane of Fig. 2 in a capillary transfer arrange- ment to effect capillary elution of DNA fragments from the gel and transfer to the membrane;
- Fig. 4 is an exploded view of a membrane processing container in accordance with the present invention
- Fig. 5 is an enlarged detail view, in cross section, of a first embodiment of a fluid port
- Fig. 6 is an enlarged detail view, similar to that of Fig. 5, of a second embodiment of a fluid port;
- Fig. 7 is an enlarged detail view of a portion of a membrane support element illustrated in Fig. 4;
- Fig. 8 is an enlarged end view of a portion of the membrane support element illustrated in Fig. 7;
- Fig. 9 is an isometric view of the elements of Fig. 4 in their assembled relationship;
- Fig. 10 is an enlarged end view, in cross section, taken along line 10-10 of Fig. 9, of the assembled membrane processing container in which selected cross sections have been enlarged out of proportion for reasons of illustration;
- Fig. 11 is a partial isometric view of an alternate construction for a portion of the membrane processing container;
- Fig. 11a is a partial isometric view of another alternate construction for a portion of the membrane processing container
- Fig. 12 is an isometric view of a mounting frame for supporting the assembled test container of Fig. 9;
- Fig. 13 is an isometric view of the mounting frame of Fig. 12 and the test container of Fig. 9 in their assembled state;
- Fig. 14 is an enlarged detail view, in cross section, illustrating the manner by which the membrane processing container is sealed;
- Fig. 15 is an isometric view of a test stand upon which the assembled membrane processing container and mounting frame are mounted for processing;
- Fig. 16 is a front partial view of the test stand of Fig. 15 with the front panel shown in dotted line illustration to reveal a pinch mechanism;
- Fig. 17 is a rear view of a controllable valving block illustrated in Fig. 15.
- the apparatus and method of the present invention is useful for the processing and treatment of solid support membranes as used in various laboratory and analytical procedures, particularly as used in molecular biology where molecules of selected materials, such as DNA, RNA, and proteins, are bound to or other ⁇ wise supported upon a membrane and subjected to various processing steps.
- the present invention will be dis- closed herein in the context of those procedures involving nucleotides, such as procedures used to identify molecules and molecule fragments of DNA and RNA.
- a membrane processing container in accordance with the present invention is designated generally by the reference character 20 and includes a bag- or sac-like jacket 22 and a membrane support 24 for supporting the membrane M as described below.
- the jacket 22 has opposite lateral sides 26 and 28, an upper closed end 30, and a normally open lower end 32.
- the jacket 22 is formed from a flexible, fluid-impervious material such as a polyethylene film having a film thickness less than 20 mils, with a three to five mil thickness preferred, that is inert to the processing fluids or a functionally equivalent material.
- the jacket has length and width dimensions sufficient to accept the membrane support 24; a length of seven or so inches and a width of five or so inches being preferred.
- the jacket 22 may be formed from a rectangu ⁇ lar sheet of polyethylene film that is folded along a mid-line to define the closed upper end 30 and sealed on its opposite lateral sides 26 and 28 by thermal, ultrasonic, adhesive, or similar bonding techniques, as indicated by the stippled seams 34 and 36, to form the jacket.
- the jacket 22 may be formed as a sleeve from a length of seamless plastic tubing that is sealed at one end to form the closed upper end 30. It is not necessary that the entire jacket 22 be formed from a flexible material.
- the jacket 22 can be formed from a rigid or semi-rigid sheet upon which another, flexible sheet is joined on three sides to yield an open ended container having a flexible wall.
- Fluid ports 38 and 40 are provided in the jacket 22 to introduce, remove, and assist in distribut ⁇ ing fluids along the opposite lateral edges of the jacket 22 as described more fully below.
- the fluid ports 38 and 40 are mounted at the closed end 30 of the jacket 22 although the ports can be mounted at other positions consistent with the fluid introducing, removing, and distribution functions.
- each port 38 and " 40 can be formed from a hollow polyethylene or similar plastic tube 42 and a hollow frusto-conical insert 44.
- the lower end of each tube 42 is positioned on the exterior side of the closed end 30 of the jacket 22 while the respective insert 44 is positioned in the interior of the jacket.
- the insert 44 is then forced into the lower end of the tube 42 with the plastic film being stretched over the surface of the insert 44 to conform to the frusto-conical interface between the insert and its mating tube.
- the frusto- conical insert 44 expands the lower end of the tube 42 to create an interference fit that captures the film between the two components with the film also rupturing at the narrow end of the insert 44 to provide an economical yet reliable leak-proof fluid connection to the interior of the jacket 22.
- the ports 38 and 40 may be connected to other apparatus, described more fully below, by flexible tubing terminated by a "Luer” slip fitting 46, as illustrated in Fig. 5. As described below, the fluid flow through the ports is interrupted by pinching the tube 42 that defines each port.
- a hollow valving insert 42a is contained within the bore of the tube 42 that defines the ports.
- the valving insert 42a is fabricated from a lower density material that is more readily deformable than the material from which the tube 42 is fabricated.
- the tube 42 is formed from a yieldable polyethylene while the valving insert is formed from a lower density and more readily deformable PVC.
- a septum 48 as shown in Fig. 6, may be pro- vided in the bore of the tubular ports 38 and 40 with fluid communication established through a hypodermic needle 50 that penetrates the septum 48 in the usual manner.
- Removable caps 52 and 54 (Fig. 4) connected by suitable tethers (unnumbered) to the respective ports 38 and 40 can be. provided to close the ports as desired.
- the membrane support 24 is defined by a rectangular sheet of an open weave polyethylene fabric 60 that is folded or creased along a mid-line to define the top and bottom sheets 56 and 58.
- the membrane support 24 is dimensioned with a width somewhat narrower and a length somewhat shorter than that of the jacket 22 to allow convenient inser- tion and removal through the open lower end 32 of the jacket.
- the open-weave fabric 60 has orthogonal weft " and woof threads that create numerous interstitial spaces on the upper and lower faces of each sheet 56 and 58.
- a fabric thickness of five to ten mils woven from a 75 to 95 micron fiber with a thread count of between 90 and 120 per inch for the weft and woof threads has been found satisfactory.
- an open- weave polyethylene fabric 60 is preferred for the top and bottom sheets 56 and 58, other materials that per- form in a functionally equivalent manner are suitable.
- Other suitable materials include perforated sheets or webs having textured, undulating, or corrugated surface characteristics that cooperate with the membrane M to form multiple fluid pathways across the surface of the membrane.
- At least one strip-like edge spacer 62 is provided on each lateral edge of the membrane support 24.
- the edge spacers 62 in their preferred form, are defined by a narrow strip of polyethylene or similar plastic that is thermally, ultrasonically, or adhesively bonded to the edge or margin of the fabric 60.
- the spacers 62 as shown in Fig. 10, have a thickness dimension sufficient to prevent the flexible walls of the jacket 22 from contacting one another along the lateral edges of the membrane support 24 to thus create lateral flow channels 64 and 66 within the jacket 22 on opposite lateral sides of the membrane support 24.
- the lateral flow channels 64 and 66 are in fluid communication with the fluid ports 38 and 40, as explained below.
- a single spacer strip 62 on each lateral edge of one of the support sheets 56 or 58 has been found satisfactory for creating the lateral flow channels 64 and 66. While spacers 62 are preferred for forming the lateral flow channels 64 and 66, the channels may also be established by placing an elongated distribution tube (not shown) on each side of the membrane support 24, or, as shown in Fig. 11, by forming a periodically interrupted linear seal 80 generally parallel to and adjacent each lateral edge of the jacket 22 and in such a manner to form a self-sustaining fluid distribution manifold 68. Where one wall of the jacket is formed from a rigid or semi-rigid sheet, as illustrated in Fig. 11a, the flexible sheet may be also be attached using a periodically interrupted liner seal 80' that is spaced from the edge seam 36.
- the membrane processing container 20 is assembled by first placing a membrane M between the top and bottom sheets 56 and 58 of the membrane support 24.
- the membrane M may be one onto which specimen molecules have been eluted from a gel matrix in accordance with the above-described Southern transfer procedure.
- the membrane M may be one with ⁇ out specimens and onto which specimens are transferred while the membrane M is contained in the membrane support 24.
- the membrane support 24 and its membrane M are laid upon one side of a gel matrix containing electrophoretically separated DNA molecules.
- the Southern transfer procedure is then used to elute the DNA molecules from the gel through the interstices of the membrane support 24 to the mem ⁇ brane M.
- the use of the membrane support 24 as part of the Southern blot procedure protects the membrane M from damage with only a minimal reduction in transfer efficiency or resolution of the resulting autoradio ⁇ graph.
- the membrane support 24 and the supported membrane are inserted, as shown in Fig. 9, through the open end 32 of the jacket 22.
- the membrane M is confined between and structurally supported by the top and bottom sheets 56 and 58 of the membrane support 24 which, in turn, are confined between the flexible walls of the jacket 22.
- the undulations of the woven top and bottom sheets 56 and 58 on the opposite sides of the membrane M create a multitude of fluid flow pathways across the opposite surfaces of the membrane M and the porosity of the membrane M permits fluid flow through the membrane from one side to the other.
- the spacers 62 prevent the opposed walls of the jacket 22 from contacting one another along the lateral edges of the membrane support 24 to create and maintain the fluid flow channels 64 and 66 along the lateral edges of the membrane support 24.
- the support frame 100 is designed to both seal the lower end 32 of the jacket 22 in a fluid-tight manner and provide a mounting that can be conveniently handled.
- the support frame 100 is formed with spaced, generally parallel side leg's 102 and 104 joined at their lower ends by a connecting leg 106 and at their upper ends by a bridge 108.
- the side and connecting legs 102, 104, and 106 are preferably formed from a rigid metal wire while the bridge 108 is formed from a sheet metal stamping that is mechanically joined to-the wire side legs 102 and 104 by any suitable means.
- the bridge 108 is formed with two spaced apart semi-cylindrical channels 110 and 112 that are dimensioned to receive the tubular fluid ports 38 and 40, respectively.
- the bridge 108 is provided with elongated slots 116 that extend orthogonally across each channel 110 and 112.
- Retaining clamps 114 one of which is shown in Fig. 12, are used to hold each fluid port in its respective receiving channel.
- the retain ⁇ ing clamps 114 are bifurcated to define port retaining tabs 114a and 114b separated by a U-shaped slot 116' that is registrable with the respective slot 116 formed in the bridge 108.
- the retaining clamps 114 are mounted on the bridge 108 prior to its being secured to the legs 102 and 104 and include turned edges 114c that maintain the clamps 114 on the bridge 108 in a slidable manner.
- the channels 110 and 112 may also be dimen ⁇ sioned to receive their respective tubular ports 38 and 40 in a resilient interference fit that allows each fluid port to be "snapped" in and out of its receiving channel. As explained below, portions of a flow pinch- off mechanism extend through each slot 116 on opposite sides of the fluid ports 38 and 40 to allow the fluid flow in each port to be interrupted or resumed.
- the lower open end 32 of the jacket 22 initially lies across the connecting leg 106.
- the lower end of the jacket is wrapped around the connecting leg 106 and held in place by a length of resilient tubing 118 formed from a plastic, rubber, or similar elastomeric material.
- the tubing 118 includes a longitudinal slit 120 and can be separated or splayed apart along its slit 120 and pushed upon the wrapped connecting leg 106, as shown in Fig. 14, to capture and seal the lower end 32 of the jacket 22 to the connecting leg 106.
- the frame 100 and the mounted membrane process ⁇ ing container 20 can be mounted on a support stand of the type shown in Fig. 15 and designated generally by the reference character 200.
- the support stand 200 includes a base 202 and an upright panel 204.
- the membrane processing container 20 is placed against the upright panel " 204 and a formed wire spring, bail or clamp 206 is placed over the two to resiliently secure the bridge 108 to the upper end of the panel 204.
- the panel 204 includes pinch clamps 208 (Fig. 16) that have cylindrical posts 210a and 210b that extend through the elongated slots 116 formed in the bridge 108 with the posts 210a and 210b positioned on opposite sides of each tubular fluid port. As shown on the left side of Fig.
- the posts 210a and 210b can be positioned in a spaced apart relationship to allow unrestricted fluid flow through the port 38 or, as shown on the right side of Fig. 15, the post 210b can be moved toward the stationary post 210a to pinch-off and interrupt any fluid flow in the port 40.
- the pinch clamps 208 are mounted on the back side of upright panel 204 and, as shown in Fig. 16, the pinch clamps include a lever 212 pivoted at one end by a pin 214 and a connecting link 216 pivotally connected to the lever 212 by a pin 218. The opposite end of the connecting link 216 carries the pin 210b for guided movement in a slot 220 (broken line illustration) formed in the panel 204.
- the pin 210a is stationary and cooperates with the moveable pin 210b to pinch off the tubular port when the lever 212 is manually moved from the solid line to the broken line positions of Fig. 16.
- the geometry of the lever 212 and the connecting link 216 can be configured so that the clamp 208 operates as a momentary action clamp or configured so that the clamp operates as a over-center toggle ON/OFF clamp.
- the membrane M upon which the specimen is deposited must first be thermally fixed by baking at a temperature high enough to effect fixing. The fixing is preferably accomplished while the membrane M is mounted in the membrane support 24.
- the membrane M, the membrane support 24 and the jacket 22 are assembled to the frame 100 as described above and the frame is mounted to the test stand 200.
- the membrane M is then subjected to a number of fluid treatment steps, described below, to produce a visible indication of the location of desired target fragments on the membrane M.
- the ports 38 and 40 of the membrane processing container 20 are connected to fluid processing system 300 that is shown in generalized schematic form.
- the system 300 includes a valve unit 302 having a fluid line 304 connected from the port 38 through the valve unit 302 to a vacuum source 306 and a fluid receiving trap 308 and another fluid line 310 connected from the port 40 through the valve unit 302 to individually valved sources of fluid 312, 314, 316, etc. which may contain probe, wash, buffer or other fluids related to the particular process or process steps.
- the valve unit 302 includes manually operable knobs 318 and 320 by which the flow through the fluid lines 304 and 310 can be controlled.
- the rear of the valve unit 302 includes two spaced parallel slots (unnumbered) which receive the fluid lines 304 and 310. The knobs
- knobs 318 and 320 are each secured to rotatably mounted shafts (not shown) with an eccentrically mounted valving cam 322 secured to the opposite ends of the shafts. Rotation of the knobs 318 and 320 causes the connected valving cam 322 to press against the typically resilient fluid lines to control flow through the lines.
- a probe solution containing radio-tagged DNA or RNA molecules complementary to the target molecules is introduced through the port 40 into the container 20 with any trapped air aspirated from the container by the vacuum source 306.
- the introduction of the probe solution and the aspiration of the trapped air may also be effected by hypodermic syringe.
- the pinch mechanisms 208 are then operated to cause the posts 210a and 210b to pinch off both fluid ports 38 and 40 and the caps 52 and 54 used to close the respective port.
- the sealed membrane processing container 20 and frame 100 are placed in an oven or water bath for an incubation period sufficient to effect annealing of the probe and target fragments. Where incubation is effected in a water bath, the weight of the frame 100 prevents the sealed membrane container 20 from floating.
- the membrane processing container 20 and the frame 100 are remounted on the support stand 200 and the bulk of the probe solution is removed by aspiration from the membrane processing container 20.
- the membrane M is then washed by applying a vacuum to the port 38 from the vacuum source 306 while allowing a wash solution to be introduced into the port 40 from one or more of the fluid sources 312, 314, or 316.
- the application of the vacuum causes the flexible walls of the jacket 22 to be pressed against the mem ⁇ brane support 24, as shown in Fig. 10, with the spacer strips 62 maintaining the lateral channels 64 and 66.
- a properly dimensioned resilient elasto- meric pad (not shown) can also be used to press the flexible wall of the jacket against the membrane support 24.
- the wash solution is transported through the fluid port 40 into and along the lateral flow channel 66.
- the wash solution then flows through the multiple fluid pathways created by the interstices of the membrane support 24 across the opposite surfaces of the membrane M to the other lateral flow channel 64 where the wash solution passes through the other fluid port 38. While the pressure differential existing between the fluid ports 40 and 38 motives the flow of the wash solution, it is also believed that the multiple fluid pathways assist by functioning as capillaries. Additional wash- ing may be provided using wash solutions of differing concentrations. The washings result in the removal of the unhybridized probe solution leaving the membrane M with its original fragments and the annealed radio- tagged probe and target fragments.
- the multiple fluid pathways defined across the surfaces of the membrane are believed to expose all portions of the membrane to the fluid flow in such a way that the fluid treatment is efficiently accomplished in a time and fluid effi ⁇ cient manner without exposing the membrane to any potentially damaging fluid flow conditions.
- the various fluid treatment steps can be conducted in a serial manner or with one or more inter ⁇ mediate "air" washings. In the latter case, air is allowed to enter the inlet port to cause the liquid from the prior fluid treatment to be entirely discharged from the jacket 22 prior to the introduction of the next fluid in the treatment sequence.
- the air washing aids in the removal of any residual liquids by entrain ⁇ ing droplets in the air flow and transporting the drop ⁇ lets to the exit port.
- the fluid port 40 may be closed, for example,.by the pinch mechanism 208 or by operation of the knob 320, and the membrane M dried in situ as a result of the applied vacuum. After drying, the entire fluid.processing container 20 can be placed against one side of a radiation sensitive film to effect exposure with the developed film revealing the location on the membrane M of the target fragments.
- the presence of the membrane support 24 and the flexible wall of the jacket 22 between the membrane M and the film does not materially affect the resolution of the resulting autoradiograph.
- the membrane support has been described as a separate component that cooperates functionally with the flexible wall jacket to define the multiple flow channels across the surface of the membrane.
- the membrane support can be secured in the jacket or formed integrally with the jacket.
- the membrane support can be installed within the jacket and permanently held in place by mechanically connecting the fabric of the membrane support with the flexible wall of the jacket, for example, by thermal, ultra ⁇ sonic, adhesive, or similar techniques.
- the membrane support and the flexible walls of the jacket can be functionally integrated in a single flexible wall material by form ⁇ ing the jacket from a material having surface character ⁇ istics, such as undulations, channels, corrugations, or the functional equivalent, that define the multiple fluid pathways.
- the present invention provides improved methods and apparatus for those procedures which utilize a membrane-bound specimen in such a way that the procedures are more time, material, and cost efficient to provide procedures better suited for clinical, industrial, and agricultural applications and eventual automation.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Environmental & Geological Engineering (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69477385A | 1985-01-25 | 1985-01-25 | |
| US694773 | 1985-01-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0209576A1 true EP0209576A1 (de) | 1987-01-28 |
Family
ID=24790216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP19860900972 Withdrawn EP0209576A1 (de) | 1985-01-25 | 1986-01-24 | System und verfahren zur behandlung von membranen |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0209576A1 (de) |
| WO (1) | WO1986004255A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4942124A (en) * | 1987-08-11 | 1990-07-17 | President And Fellows Of Harvard College | Multiplex sequencing |
| US4812216A (en) * | 1987-08-28 | 1989-03-14 | Bios Corporation | Method of handling and transporting a transfer membrane used in a blotting apparatus |
| GB8724023D0 (en) * | 1987-10-13 | 1987-11-18 | Donovan K O | Handling blot processing |
| GB8919145D0 (en) * | 1989-08-23 | 1989-10-04 | Royal Postgrad Med School | Apparatus for the in situ hybridisation of slide-mounted cell samples |
| JPH055723A (ja) * | 1990-11-05 | 1993-01-14 | Herena Kenkyusho:Kk | 電気泳動用試薬供給方法および薄層試薬供給体 |
| WO1996039627A1 (en) | 1994-05-13 | 1996-12-12 | Peter Schmid | Apparatus and method for attaching a labeled probe and/or antibody to macromolecules |
| EP0871876A4 (de) * | 1995-06-05 | 1999-12-22 | Peter Schmid | Vorrichtung und verfahren um eine markierte probe und/oder einen antikörper an makromolekülen zu binden |
| GB2332158B (en) * | 1995-08-28 | 1999-11-24 | Millipore Invest Holdings | Centrifugal adsorptive sample preparation device and method |
| US5770086A (en) * | 1996-01-25 | 1998-06-23 | Eureka| Science Corp. | Methods and apparatus using hydrogels |
| DE102004057107B8 (de) * | 2004-11-26 | 2016-07-28 | A3 Water Solutions Gmbh | Rahmenloser, plattenförmiger Filtrationskörper und Filtrationsmodul |
| EP3224207B1 (de) * | 2014-11-26 | 2025-05-07 | Evoqua Water Technologies LLC | Verfahren und systeme zur bereitstellung von ein- und auslässen für zellenpaare in einer elektrochemischen trennvorrichtung |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE522875A (de) * | 1952-09-23 | |||
| US3332216A (en) * | 1964-03-16 | 1967-07-25 | Union Carbide Corp | Fluid permeation apparatus |
| US3483887A (en) * | 1965-03-24 | 1969-12-16 | Drager Otto H | Breathing apparatus |
| US3490523A (en) * | 1968-04-08 | 1970-01-20 | Us Health Education & Welfare | Transfer device |
| GB1270932A (en) * | 1968-04-25 | 1972-04-19 | Calmic Eng Co Ltd | Dialysis apparatus |
| US3811800A (en) * | 1972-07-12 | 1974-05-21 | K Shill | Blood pump |
| US4009287A (en) * | 1972-08-24 | 1977-02-22 | Imperial Chemical Industries Limited | Containers for packaging liquids |
| FR2231411B1 (de) * | 1973-05-29 | 1978-06-30 | Rhone Poulenc Sa | |
| US4493815A (en) * | 1983-07-28 | 1985-01-15 | Bio-Rad Laboratories, Inc. | Supporting and filtering biochemical test plate assembly |
-
1986
- 1986-01-24 EP EP19860900972 patent/EP0209576A1/de not_active Withdrawn
- 1986-01-24 WO PCT/US1986/000112 patent/WO1986004255A1/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO8604255A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1986004255A1 (en) | 1986-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10906039B2 (en) | Fluid processing and control | |
| EP0209576A1 (de) | System und verfahren zur behandlung von membranen | |
| US4576702A (en) | Analytical electroelution device | |
| US4964961A (en) | Elution method and device | |
| US11927600B2 (en) | Fluidic bridge device and sample processing methods | |
| US4795562A (en) | Membrane batch-processing apparatus | |
| EP1706735B1 (de) | Mehrdimensionale elektrophoresevorrichtung | |
| JP2002542024A (ja) | サンプル送達のための装置および方法 | |
| JP2009533048A (ja) | 貫流セルのための抑泡薄膜 | |
| JP5014552B2 (ja) | ピペットアクセスのための開口を有する処理チャンバ | |
| US4804469A (en) | Flexible jacket membrane processing apparatus | |
| AU2001262612A1 (en) | Processing Chamber | |
| US4892662A (en) | Membrane processing method | |
| CN106233132B (zh) | 生物体分子分析装置 | |
| HK1072023B (en) | Fluid processing and control | |
| HK1072023A (en) | Fluid processing and control |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LI LU NL SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 19861230 |